Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates

Go back to Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates
(NASDAQ: IOVA) Delayed: 10.19 +0.32 (3.24%)
Previous Close $9.87    52 Week High
Open $10.25    52 Week Low
Day High $10.98    P/E N/A 
Day Low $10.15    EPS
Volume 15,844,030